OPHTAI WAS INVOLVED IN A LARGE TELERETINAL SCREENING PROGRAM ORGANIZED BY UNIVERSITY OF WASHINGTON TO ASSESS DIABETIC RETINOPATHY ON 23,724 PATIENTS AT HOSPITALS IN SEATTLE AND ATLANTA On January 7, 2021, Aaron Lee’s article in the ADA Diabetes Care was...
OphtAI is very proud to be one of the 5 AI solutions selected for a real world validation study performed by Pr. Aaron Lee and published in the prestigious ADA Diabetes Care Journal.The OphtAI solution is one of the two solutions deemed to be usable in all...
World Health Organization’s recent study, ‘world report on vision 2019’ revealed that population growth and ageing—along with lifestyle changes and urbanization—will ‘dramatically increase’ the number of people with eye conditions, vision impairment, and blindness in...
Recent Comments